Variable | Category/term | Odds ratio (95% CI) | P-value |
---|---|---|---|
Model 1 | Â | Â | Â |
ACE/ARB | No | 1 | <0.001 |
 | Yes | 1.73 (1.41, 2.11) |  |
Model 2 | Â | Â | Â |
ACE/ARB | No | 1 | <0.001 |
 | Yes | 1.62 (1.31, 1.99) |  |
Age (*) | Linear term | 0.44 (0.30, 0.67) | <0.001 |
 | Quadratic term | 1.09 (1.06, 1.13) |  |
Sex | Female | 1 | 0.21 |
 | Male | 1.15 (0.92, 1.43) |  |
Model 3 | Â | Â | Â |
ACE/ARB | No | 1 | 0.85 |
 | Yes | 1.02 (0.81, 1.29) |  |
Age (*) | Linear term | 0.43 (0.27, 0.68) | <0.001 |
 | Quadratic term | 1.08 (1.04, 1.12) |  |
Sex | Female | 1 | 0.34 |
 | Male | 1.12 (0.89, 1.40) |  |
Hypertension | Â | 1.87 (1.27, 2.74) | 0.001 |
Diabetes | Â | 1.69 (1.33, 2.15) | <0.001 |
IHD | Â | 0.96 (0.73, 1.25) | 0.75 |
Heart Failure | Â | 2.09 (1.44, 3.05) | <0.001 |
Systolic BP < 100 |  | 4.37 (3.18, 5.99) | <0.001 |
CKD stage | 1 | 1 | <0.001 |
 | 2 | 1.32 (1.01, 1.71) |  |
 | 3 | 1.78 (1.29, 2.45) |  |
 | 4 | 2.39 (1.47, 3.91) |  |
Diuretic | Â | 1.66 (1.34, 2.06) | <0.001 |
Model 4 | Â | Â | Â |
ACE/ARB | No | 1 | 0.17 |
 | Yes | 0.83 (0.63, 1.09) |  |
Age (*) | Linear term | 0.47 (0.24, 0.93) | <0.001 |
 | Quadratic term | 1.07 (1.02, 1.12) |  |
Sex | Female | 1 | 0.79 |
 | Male | 1.06 (0.81, 1.40) |  |
Hypertension | Â | 2.17 (1.29, 3.65) | 0.003 |
Diabetes | Â | 1.32 (0.99, 1.74) | 0.06 |
IHD | Â | 1.07 (0.78, 1.46) | 0.69 |
Heart Failure | Â | 1.66 (1.07, 2.56) | 0.02 |
Systolic BP < 100 |  | 4.34 (2.96, 6.36) | <0.001 |
CKD stage | 1 | 1 | 0.47 |
 | 2 | 1.16 (0.85, 1.56) |  |
 | 3 | 1.31 (0.89, 1.92) |  |
 | 4 | 1.38 (0.76, 2.45) |  |
Diuretic | Â | 1.56 (1.20, 2.02) | 0.001 |
Proteinuria | None | 1 | <0.001 |
 | Moderate | 1.62 (1.21, 2.17) |  |
 | Severe | 3.43 (2.22, 5.29) |  |